Alendronate osteoporosis drug molecule

Alendronate osteoporosis drug molecule

A624/0400 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 47.2MB

Downloadable file size: 549.7KB

Price image Pricing

Please login to use the price calculator


Caption: Alendronate osteoporosis drug, molecular model. Alendronate is marketed as Fosamax, or as Fosavance when combined with vitamin D. It is a bisphosphonate drug, which works by blocking the resorption of bone by osteoclast bone cells. The treatment requires healthy levels of calcium and vitamin D, so if the underlying problem is with levels of either of those, that must be corrected before the course starts. In this molecule, atoms are shown as blobs and are colour-coded: carbon (green), nitrogen (blue), hydrogen (white), phosphorus (orange) and oxygen (red).

Release details: Model release not required. Property release not required.

Keywords: ageing, alendronate, artwork, biochemical, biochemistry, bisphosphonate, bone, bones, brittle bone disease, chemical, chemistry, compound, compounds, computer artwork, density, drug, elderly, fosamax, fosavance, illustration, mass, medical, medicine, molecular, molecular model, molecule, molecules, one, osteoporosis, pharmaceutical, pharmaceutics, pharmacological, pharmacology, resorption, single, space fill, sphere, spheres

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.